UK Biotech’s US Antibody Patents Upheld in Regeneron Battle
UK biotech Kymab has won the latest skirmish in its ongoing legal battle with the US giant Regeneron regarding patents protecting their rival antibody-producing technologies. The outcome of the battle could have big implications...
What’s old is new again
Researchers repurpose classic chemotherapy drug to overcome cancer therapy resistance
Credit: Image/Art credit: Mark Miller, Stowers Institute
KANSAS CITY, MO–Drug resistance is a major obstacle in cancer treatment–leading...